Action SNNUF SMITH & NEPHEW PLC
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Communiqués Smith & Nephew Plc OTC Markets

Actions

SNNUF

GB0009223206

Marché Fermé - OTC Markets
Autres places de cotation
 17:21:10 21/06/2024 		Varia. 5j. Varia. 1 janv.
12,78 USD +0,59% Graphique intraday de Smith & Nephew Plc -.--% -7,83%
10:23 Les actions de Smith & Nephew montent en flèche après la révélation de la participation de l'investisseur activiste Cevian RE
10:10 Smith & Nephew prend une participation de 5% grâce à Cevian Capital AN

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Smith+Nephew takes centre court sponsoring players competing at Wimbledon; global Sports Medicine technology leader helping athletes get back in the game
GL
Smith+Nephew Personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH Pre-Operative Planning and Modeling Services exclusively for the CORI Surgical System
AQ
Smith+Nephew personalizes robotic-assisted surgery for patients and surgeons with launch of CORIOGRAPH™ Pre-Operative Planning and Modeling Services exclusively for the CORI™ Surgical System
GL
Smith & Nephew : NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM - Form 6-K
PU
Smith & Nephew : Director/Pdmr Shareholding - Form 6-K
PU
4 Stocks to Watch in the Booming Regenerative Medicine Market
AQ
Smith & Nephew : STERLING AMOUNT OF DIVIDEND - Form 6-K
PU
Smith & Nephew : Directorate Change - Form 6-K
PU
Smith+Nephew Announces new evidence supporting ALLEVYN LIFE Foam Dressing's role in pressure injury prevention
AQ
Smith+Nephew announces new evidence supporting ALLEVYN LIFE Foam Dressing’s role in pressure injury prevention  
GL
Smith+Nephew’s PICO™ Single Use Negative Pressure Wound Therapy System provides better clinical outcomes versus standard of care according to UK National Institute for Health and Care Excellence (NICE)
GL
Smith+Nephew introduces the RENASYS™ EDGE Negative Pressure Wound Therapy System – an exciting new option in home-based care for patients living with chronic wounds
GL
Smith & Nephew : Directorate Change - Form 6-K
PU
Smith+Nephew teams up with UFC to be first-ever Preferred Sports Medicine Technology Partner
GL
Smith & Nephew : Notice of Annual General Meeting
PU
Smith+Nephew and U.S. Army Institute of Surgical Research to engage in Master Cooperative Research and Development Agreement
GL
Smith & Nephew : +Nephew Fourth Quarter and Full Year 2023 Results
PU
Smith+Nephew announces commercial launch of its AETOS™ Shoulder System for anatomic and reverse shoulder replacement at AAOS 2024 Annual Meeting
GL
Smith+Nephew to showcase leading, innovative AI-driven robotic-assisted solutions for personalized orthopaedic surgery at AAOS 2024 Annual Meeting  
GL
Smith+Nephew unveils expanded Sports Medicine portfolio to enable biological healing at AAOS 2024 Annual Meeting
GL
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action SN.
  4. Action SNNUF
  5. Actualités Smith & Nephew Plc
  6. Communiqués